Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Fund Triples Holding of Drug Repurposing Firm

<< Previous

Bullboard Posts

Next >>

Comment by CASHEAGLEon Jan 22, 2022 8:14pm

136 Views

Post# 34348883

RE:RE:Fund Triples Holding of Drug Repurposing Firm

You dont like "pennyland" but post almost daily on penny stocks with a focus to defame a certain group ..you will be identified and held accountable..govern your welfare accounts accordingky You post nothing about where you are making money...is there an ulterior motive or vengence why ytou focus on posting on stocks you "hate"..just to enlighten investors as good will?...lets see where your rear end ends up in 2022 with your defmation posts qnd claims to be some sort of Chat site CEO

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?